Presenting this month:
Nanomagnetic Targeting Systems: NTS is an early stage company founded in Oklahoma City. NTS’s mission and focus is to develop, manufacture and market magnetically targeted drug delivery systems. The platform system is based on proprietary magnetic nanoformulations attached to therapeutic payload(s), and its non-invasive proprietary magnetic guiding system. NTS is currently working on Targeting System to treat Atrial Fibrillation (AF), the most common cardiac arrhythmia.
MaxQ: A provider of validated cold chain packaging solutions for the life sciences industry. The flagship Max+ series of blood packaging systems are utilized for safe handling, storage, and transportation of blood products, vaccines, pharmaceuticals etc. MaxQ customers include: Blood Banks, Mayo Clinic, hospital and healthcare systems and level 1 trauma centers in the U.S. and abroad.
